Dr. Mechoulam’s latest discovery is called EPM301, or cannabidiolic acid methyl ester, also known as CBDa. EPM stands for Endless Potential Molecules, and there are now around 14 patented molecules that are being tested on humans with the US FDAs guidance. The first targets of EPM are psoriasis and inflammatory bowel disease (IBD), which are notoriously difficult to treat.
The AEW star gets candid about loss, love, life on the road, and the role…
Sara Carter, the former investigative journalist and Fox News contributor now serving as White House…
Weed may be legal in much of America, but for non-citizens, one hit, one job,…
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…
The agency has quietly sent a CBD compliance and enforcement policy to the White House…
When renowned US film director Paul Thomas Anderson and production designer Florencia Martin visited the…